Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?
AMA J Ethics. 2016;18(6):624-632. doi:
10.1001/journalofethics.2016.18.6.msoc1-1606.
The clinician/healer must both address the disease and seek to know how the medical condition is being experienced by the patient—what impact it has on his or her life and spirit.
Being marked as an “other” outside of the circle of human concern expresses tension between principles of liberty and equality and exacerbates health inequity.
AMA J Ethics. 2021;23(2):E166-174. doi:
10.1001/amajethics.2021.166.